melphalan hydrochloride kit
dr.reddy's laboratories inc - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan hydrochloride for injection should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan hydrochloride for injection should not be given the drug.
melphalan hydrochloride kit
meitheal pharmaceuticals inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.
melphalan hydrochloride kit melphalan hydrochloride injection, powder, lyophilized, for solution
noratech pharmaceuticals, inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.
alkeran
glaxosmithkline nz limited - melphalan 2mg - tablet - 2 mg - active: melphalan 2mg excipient: colloidal silicon dioxide crospovidone gelatin hypromellose macrogol 400 magnesium stearate microcrystalline cellulose titanium dioxide
alkeran tablets 2 mg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - melphalan 2 mg - 2 mg
alkeran 2 mg film-coated tablets
aspen pharma trading limited - melphalan - film-coated tablet - 2 milligram(s) - nitrogen mustard analogues; melphalan
evomela- melphalan injection, powder, lyophilized, for solution
acrotech biopharma llc - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - evomela is indicated for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. history of serious allergic reaction to melphalan. risk summary based on its mechanism of action, evomela can cause fetal harm when administered to a pregnant woman, including teratogenicity and/or embryo-fetal lethality [see clinical pharmacology (12.1)] . melphalan is a genotoxic drug and can cause chromatid or chromosome damage in humans [see nonclinical toxicology (13.1)] . in animal studies, melphalan was embryolethal and teratogenic in rats at doses below the recommended clinical doses [see data] . advise a pregnant woman of the potential risk to a fetus.. the background risk of major birth defects and miscarriage for the indicated populations are unknown. however, the background risk in the u.s. general population of major birth defects is 2-4% and of miscarriage is 15-20% of clinically recognized pregnancies. data animal data adequate ani
alkeran tablets 2mg
aspen medical products malaysia sdn bhd - melphalan -
alkeran tablet 2 mg (revised formula)
dch auriga singapore - melphalan - tablet, film coated - 2.00 mg - melphalan 2.00 mg
alkeran
excella gmbh & co.kg - melphalan - tablets film-coated - 2mg